Eterna Therapeutics
ERNA
#10032
Rank
โ‚ฌ9.96 M
Marketcap
0,15ย โ‚ฌ
Share price
-3.35%
Change (1 day)
-92.28%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of April 2025 : 6.76

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 19.7648.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-317.6475.7%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.11-68.80%๐Ÿ‡บ๐Ÿ‡ธ USA
3.07-54.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.16-131.88%๐Ÿ‡บ๐Ÿ‡ธ USA
1.56-76.96%๐Ÿ‡ซ๐Ÿ‡ท France
3.66-45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-55.24%๐Ÿ‡ฆ๐Ÿ‡บ Australia
2.73-59.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel